We specialise in full-service custom research and consultancy for global healthcare. We use the full range of qualitative and quantitative techniques to undertake both ad hoc and tracking studies across a range of therapy areas and territories
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.
Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients and consumers to deliver integrated insights.
Medical devices and diagnostics
Our experience covers everything from insulin pens to large-scale surgical console systems. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.
- Some example case studiesWargaming in HCV
The challengeOur client had a product ready for launch in the HCV landscape. A number of new competitor products were expected to alter the market dynamics. Given the stage of development of both our client’s product and the competitors, a number of different scenarios could have played out. Consequently, the company wanted to conduct research in order to feed into strategy development for their product.…read more »Patient Assistance Programme Evaluation for Cardiovascular Conditions
The challengeOur client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product. The client wanted to understand how successful the PAP was at meeting the needs of patients, trainers and prescribers, and whether it positively differentiated them from competitors. They wanted to evaluate each individual component…read more »Multiple Sclerosis new medical device research
The challengeOur client wanted to find out how best to develop an implantable delivery device with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a device would be accepted by HCPs and patients. We also needed to identify the perceived benefit to stakeholders and offer ideas on how to optimize the device offering through the look of the…read more »
- Our latest white papersWill gene therapies finally be commercially viable to pharma?
Our latest Free Thinking white paper explores the science behind the idea of gene therapy and takes a look at some of the core challenges medical researchers have faced when attempting to develop this technology. We review gene therapy’s chequered past, look at recent developments in this field and consider the future for gene therapies on their way to market.read more »Understanding the chronic disease patient journey in emerging markets
In this paper, we explore the chronic disease patient journey in emerging markets and provide you with the insights you require to identify the key inflection points in these rapidly changing and diverse regions.read more »